US · Healthcare

Eterna Therapeutics Inc (ERNA)

Biotechnology

Eterna Therapeutics Inc (ERNA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ERNA

P/E ratio

25.00

Eterna Therapeutics Inc (ERNA) — FAQ

What is ERNA's P/E ratio?

The price-to-earnings (P/E) ratio for Eterna Therapeutics Inc (ERNA) is 25.00 (data as of 2026-05-23).

Does Eterna Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Eterna Therapeutics Inc (ERNA). Check the MyAverix Finance app for the latest dividend data.

What sector is Eterna Therapeutics Inc in?

Eterna Therapeutics Inc (ERNA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ERNA listed on?

ERNA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)